Additional experiments reported by Wong et al. [95] provided evidence that the development of resistance in anaplastic thyroid cancer was at least in part caused by the increased expression of cyclin D3 and upregulated CDK4/6 activity. The gene discussed is CDK4; the disease is thyroid gland undifferentiated (anaplastic) carcinoma.